Postmarketing Trials for Rare Diseases

被引：0
|
作者：
Llera, Virginia A. [1 ]
Roldan, Emilio J. A. [1 ]
机构：
[1] GEISER Fdn, RA-5500 Mendoza, Argentina
来源：
SCIENCE | 2012年 / 337卷 / 6091期
关键词：
D O I：
10.1126/science.337.6091.154-b
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [1] Strategies for Postmarketing Surveillance of Drugs for Rare Diseases
    Kesselheim, A. S.
    Gagne, J. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (03) : 265 - 268
  • [2] Clinical trials and rare diseases
    Lagakos, SW
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24): : 2455 - 2456
  • [3] Clinical Trials and Rare Diseases
    Gerss, Joachim Werner Otto
    Koepcke, Wolfgang
    RARE DISEASES EPIDEMIOLOGY, 2010, 686 : 173 - 190
  • [4] The challenges of clinical trials in rare diseases
    Mellerio, Jemima E.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (04) : 453 - 454
  • [5] Trials and tribulations of rare eye diseases
    Shetty, Rohit
    Sethu, Swaminathan
    Jayadev, Chaitra
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (07) : 2216 - 2217
  • [6] Methodology of clinical trials for rare diseases
    Smith, Catrin Tudur
    Williamson, Paula R.
    Beresford, Michael W.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2014, 28 (02): : 247 - 262
  • [7] Tackling rare diseases: Clinical trials on chips
    Blumenrath, Sandra H.
    Lee, Bo Y.
    Low, Lucie
    Prithviraj, Ranjini
    Tagle, Danilo
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 245 (13) : 1155 - 1162
  • [8] Innovative methodologies for rare diseases clinical trials
    Nabbout, Rima
    Hilgers, Ralf-Dieter
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [9] Clinical trials in rare diseases: a review of practice
    Stuart Bell
    Paula Williamson
    Simon Day
    Keith Wheatley
    John Whitehead
    Catrin Tudur Smith
    Trials, 14 (Suppl 1)
  • [10] WHICH EFFICACY TRIALS FOR DRUGS FOR RARE DISEASES?
    Traversa, Giuseppe
    Trotta, Francesco
    EPIDEMIOLOGIA & PREVENZIONE, 2017, 41 (5-6): : 318 - 319
12345